Contact Information: Contact: Dino Luzzi CEO Medivisor, Inc. Tel: 631.549.7100
Medivisor, Inc. Receives Initial Purchase Order
| Source: Medivisor, Inc.
HUNTINGTON STATION, NY--(Marketwire - September 24, 2008) - Medivisor, Inc. (PINKSHEETS : MVSR )
developer of next-generation, focus driven marketing tools primarily for
pharmaceutical companies, is pleased to announce that it has received a
purchase order for Albumax from Critical Healthcare Solutions, Inc. for
their East Goshen Pharmacy Inc. unit.
"After completing our sales and marketing agreement for Albumax just a few
weeks ago, our initial marketing efforts are already starting to pay off.
We are already beginning to see a strong interest in the product, have
received Medicaid approval in New York, and are pleased to announce this
initial purchase order for Albumax in such a short period of time," stated
Dino Luzzi, CEO of Medivisor, Inc. "Our marketing efforts are just getting
underway and as we continue to bring awareness of Albumax to the
marketplace, we anticipate further purchase order announcements," continued
Mr. Luzzi.
Under a recently announced agreement with Cura Pharmaceutical Co., Inc.
Medivisor is responsible for marketing and sales of Albumax, a whey protein
isolate formula that makes it easy for kidney disorder patients to reach
their daily requirements of high quality protein in their diet. Patients
and those in the Medical Profession can now go to www.albumax.net to order
or inquire about the product.
About Medivisor, Inc.:
Medivisor, Inc. is a developer of next-generation, focus driven marketing
tools, dedicated to providing technologies that offer innovative and
competitive advantages to the bioscience and pharmaceutical markets. From
pre-product development through product launch and commercialization,
Medivisor offers worldwide experience in delivering effective and
successful integrated marketing and creative communications campaigns for
the benefit of its clients.
Safe Harbor
This press release contains forward-looking statements within the meaning
of the Private Securities Litigation Reform Act of 1995 (the "Act")
Additionally, words such as "seek," "intend," "believe," "plan,"
"estimate," "expect," "anticipate" and other similar expressions are
forward-looking statements within the meaning of the Act. Some or all of
the events or results anticipated by these forward-looking statements may
not occur. Further information on Medivisor risk factors is contained in
its filings with the Securities and Exchange Commission. Medivisor does not
undertake any duty nor does it intend to update the results of these
forward-looking statements.